Document is current
Any future updates will be listed below
-
Authors
Boras, Britton
Jones, Rhys M. https://orcid.org/0000-0002-5263-9194
Anson, Brandon J. https://orcid.org/0000-0003-2670-974X
Arenson, Dan
Aschenbrenner, Lisa
Bakowski, Malina A. https://orcid.org/0000-0002-3337-6528
Beutler, Nathan https://orcid.org/0000-0003-3240-9524
Binder, Joseph
Chen, Emily
Eng, Heather https://orcid.org/0000-0002-2914-3967
Hammond, Holly
Hammond, Jennifer
Haupt, Robert E.
Hoffman, Robert https://orcid.org/0000-0002-2030-9094
Kadar, Eugene P.
Kania, Rob
Kimoto, Emi https://orcid.org/0000-0003-1284-2769
Kirkpatrick, Melanie G.
Lanyon, Lorraine
Lendy, Emma K.
Lillis, Jonathan R.
Logue, James https://orcid.org/0000-0002-7410-9741
Luthra, Suman A.
Ma, Chunlong https://orcid.org/0000-0002-5766-8189
Mason, Stephen W.
McGrath, Marisa E. https://orcid.org/0000-0002-7451-4958
Noell, Stephen
Obach, R. Scott
O’ Brien, Matthew N.
O’Connor, Rebecca
Ogilvie, Kevin https://orcid.org/0000-0002-1024-2172
Owen, Dafydd
Pettersson, Martin
Reese, Matthew R. https://orcid.org/0000-0002-1066-2652
Rogers, Thomas F. https://orcid.org/0000-0001-9756-327X
Rosales, Romel https://orcid.org/0000-0001-5326-4753
Rossulek, Michelle I.
Sathish, Jean G.
Shirai, Norimitsu
Steppan, Claire
Ticehurst, Martyn
Updyke, Lawrence W.
Weston, Stuart https://orcid.org/0000-0001-9840-2953
Zhu, Yuao
White, Kris M. https://orcid.org/0000-0003-0889-0506
García-Sastre, Adolfo https://orcid.org/0000-0002-6551-1827
Wang, Jun https://orcid.org/0000-0002-4845-4621
Chatterjee, Arnab K.
Mesecar, Andrew D.
Frieman, Matthew B. https://orcid.org/0000-0003-0107-0775
Anderson, Annaliesa S. https://orcid.org/0000-0002-6413-1718
Allerton, Charlotte https://orcid.org/0000-0001-8665-159X
-
Funding
Funding for this research was provided by:
Pfizer
U.S. Department of Defense (W81XWH-20-1-0270)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U19AI142733, U19AI135972)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
- License Information
-
More Information
Article History
Received: 22 January 2021
Accepted: 23 September 2021
First Online: 18 October 2021
Competing interests
: A.D.M. and affiliates (B.J.A., E.K.L.) have a sponsored program contract with Pfizer to test compounds for inhibition of coronavirus proteases. J.W. and affiliate (C.M.) have a sponsored research agreement with Pfizer to test compounds for inhibition of coronavirus proteases. The Frieman Laboratory (M.B.F., H.H., R.E.Ha., J.L., M.E.M., S.W.) was funded by Pfizer for the work in this manuscript. The García-Sastre Laboratory (AG-S, KMW, RR) has received research support from Pfizer, Senhwa Biosciences, Accurius, Avimex, 7Hills Pharma, Pharmamar, Blade therapeutics, Dynavax, Kenall Manufacturing, ImmunityBio and Nanocomposix; and AG-S has consulting agreements for the following companies involving cash and/or stock: Vivaldi Biosciences, Contrafect, 7Hills Pharma, Avimex, Valneva, Accurius, and Esperovax. AG-S is inventor in patent applications on SARS-CoV-2 antivirals owned by Icahn School of Medicine at Mount Sinai. B.B., R.M.J., D.A., L.A., J.B., H.E., J.H., R.Ho., E.P.K., R.K., E.K., L.L., J.R.L., S.A.L., S.W.M., S.N., R.S.O., M.N.O., R.O., K.O., D.O., M.P., M.R.R., M.I.R., J.G.S., N.S., C.S., M.T., L.W.U., Y.Z., A.A., and C.A., at the time of their contributions were employees and may have stock in Pfizer. A.K.C., M.A.B., N.B., E.C., M.G.K., T.F.R. have no competing interest to report.
